Clinical Trial

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a multi-center, parallel-group, open-label, randomized, Phase 1b study to explore the safety, clinical activity, pharmacokinetics and pharmacodynamics of DR-01 in adults with Alopecia Areata or Vitiligo.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2024-09-16; most recent amendment 2026-07-07.
Status change: Recruiting → Active, Not Recruiting 2026-05-07
Status change: Not Yet Recruiting → Recruiting 2024-10-01
Trial Details
NCT Number NCT06602232
Lead Sponsor Dren Bio
Conditions Alopecia Areata, Vitiligo
Enrollment 81 participants
Start Date 2024-10-30
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-08